EO771, the first luminal B mammary cancer cell line from C57BL/6 mice

Cancer Cell International
Augustin Le NaourAdrien Rossary

Abstract

Despite decades of therapeutic trials, effective diagnosis, many drugs available and numerous studies on breast cancer, it remains the deadliest cancer in women. In order to choose the most appropriate treatment and to understand the prognosis of the patients, breast cancer is divided into different subtypes using a molecular classification. Just as there remains a need to discover new effective therapies, models to test them are also required. The EO771 (also named E0771 or EO 771) murine mammary cancer cell line was originally isolated from a spontaneous tumour in C57BL/6 mouse. Although frequently used, this cell line remains poorly characterized. Therefore, the EO771 phenotype was investigated. The phenotype was compared to that of MCF-7 cells, known to be of luminal A subtype and to express estrogen receptors, as well as MDA-MB-231 cells, which are triple negative. Their sensitivity to hormonal treatment was evaluated by viability tests. The EO771 were estrogen receptor α negative, estrogen receptor β positive, progesterone receptor positive and ErbB2 positive. This phenotype was associated with a sensitivity to anti-estrogen treatments such as tamoxifen, 4-hydroxy-tamoxifen, endoxifen and fulvestrant. On account of the nu...Continue Reading

References

Oct 1, 1987·Molecular Endocrinology·R WhiteM Parker
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Dec 6, 2002·Nature·UNKNOWN Mouse Genome Sequencing ConsortiumEric S Lander
Apr 18, 2003·Cancer Chemotherapy and Pharmacology·Eric DebitonChantal Barthomeuf
Apr 13, 2004·Oncogene·Teiji Wada, Josef M Penninger
Sep 3, 2004·The New England Journal of Medicine·Corrine K WeltChristos S Mantzoros
Mar 31, 2009·International Journal of Cancer. Journal International Du Cancer·Christina RestallAnthony E Dear
Sep 3, 2011·Breast Cancer Research : BCR·Deborah L Holliday, Valerie Speirs
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Vida VafaizadehBernd Groner
Nov 7, 2012·Journal of Cellular Physiology·Bruno LamasMarie-Chantal Farges
Dec 4, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaofeng ChenYongmei Yin
Dec 13, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aleix PratCharles M Perou
Jan 3, 2013·Current Medicinal Chemistry·F LumachiS M M Basso
Apr 9, 2013·Molecular and Cellular Endocrinology·Priscilla A Furth
Jun 1, 2014·Virchows Archiv : an International Journal of Pathology·Darina VuongSunil R Lakhani
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Felipe AdesMartine Piccart
Aug 9, 2015·The Breast : Official Journal of the European Society of Mastology·Aleix PratMontserrat Muñoz
Mar 31, 2016·Journal of Cellular Physiology·Aurore CollinMarie-Chantal Farges
May 22, 2016·Carcinogenesis·Silvia Juliana Serrano-GomezJovanny Zabaleta
Apr 5, 2017·Journal of the National Cancer Institute·Ran MaJohan Hartman
Nov 4, 2017·Progress in Molecular Biology and Translational Science·Stella WintersNavkiran K Shokar
Jan 24, 2018·Journal of Applied Physiology·Linda A Buss, Gabi U Dachs

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

GraphPad Prism5

Related Concepts

Related Papers

Proceedings of the Society for Experimental Biology and Medicine
A E CASEYG L ROSS
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Marie GoeppMarie-Paule Vasson
© 2021 Meta ULC. All rights reserved